HomePharma

Pharma

Pharma

EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

Life Sciences Times - 0
Pharma

Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™

Life Sciences Times - 0
Pharma

Greenwich LifeSciences Expands Role of Industry Expert Dr. F. Joseph Daugherty to Include Medical Monitor for its Upcoming Phase III Clinical Trial

Life Sciences Times - 0
Pharma

Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival...

Life Sciences Times - 0
Pharma

U.S. Food and Drug Administration Accepts for Priority Review supplemental Biologics License Application for Reblozyl

Life Sciences Times - 0
Pharma

Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021

Life Sciences Times - 0
Pharma

Pulmotect Provides Results from Two Randomized, Placebo Controlled Phase-2 Trials of PUL-042 Against COVID-19

Life Sciences Times - 0
Pharma

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

Life Sciences Times - 0
Pharma

FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical Models (Mouse Models)

Life Sciences Times - 0
Pharma

VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults

Life Sciences Times - 0
Pharma

Alzamend Neuro Announces Date for Delivery of Topline Data for Phase 1 First-in-Human Clinical Trial for AL001 for Dementia Related to Alzheimer’s

Life Sciences Times - 0
Pharma

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS

Life Sciences Times - 0
1...666768...91Page 67 of 91

Most Read